Nymox Pharmaceutical Corporation (NYMX): Price and Financial Metrics


Nymox Pharmaceutical Corporation (NYMX)

Today's Latest Price: $1.91 USD

0.01 (0.53%)

Updated Nov 21 8:00pm

Add NYMX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

NYMX Stock Summary

  • The ratio of debt to operating expenses for Nymox Pharmaceutical Corp is higher than it is for about merely 0.39% of US stocks.
  • NYMX's price/sales ratio is 410.99; that's higher than the P/S ratio of 99.32% of US stocks.
  • With a year-over-year growth in debt of -100%, Nymox Pharmaceutical Corp's debt growth rate surpasses just 0% of about US stocks.
  • Stocks that are quantitatively similar to NYMX, based on their financial statements, market capitalization, and price volatility, are PRTA, KDMN, GERN, WATT, and NBRV.
  • Visit NYMX's SEC page to see the company's official filings. To visit the company's web site, go to www.nymox.com.
NYMX Daily Price Range
NYMX 52-Week Price Range

NYMX Stock Price Chart More Charts


NYMX Price/Volume Stats

Current price $1.91
Prev. close $1.90
Day low $1.84
Day high $1.92
50-day MA $1.92
200-day MA $1.86
52-week high $2.75
52-week low $1.25
Volume 29,700
Avg. volume 95,121
Dividend yield N/A
Market Cap 129.26M

Nymox Pharmaceutical Corporation (NYMX) Company Bio


Nymox Pharmaceutical Corporation engages in the research and development of drugs for the aging population. It markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. The company also offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer’s disease. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in Phase III clinical trials for the treatment of enlarged prostate or benign prostatic hyperplasia, as well as is in Phase II clinical trial for low grade localized prostate cancer. The company was founded in 1989 and is based in Nassau, The Bahamas.





NYMX Latest News Stream


Event/Time News Detail
Loading, please wait...

NYMX Latest Social Stream


Loading social stream, please wait...

View Full NYMX Social Stream

NYMX Price Returns

1-mo 4.37%
3-mo 13.02%
6-mo 20.13%
1-year 1.60%
3-year -37.99%
5-year 235.09%
YTD 45.80%
2018 -60.30%
2017 23.60%
2016 -18.60%
2015 720.00%
2014 -93.41%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7775 seconds.